Angiodynamics (ANGO) Receivables (2016 - 2025)
Historic Receivables for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $44.4 million.
- Angiodynamics' Receivables rose 295.66% to $44.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was $44.4 million, marking a year-over-year increase of 295.66%. This contributed to the annual value of $42.9 million for FY2025, which is 165.1% down from last year.
- Per Angiodynamics' latest filing, its Receivables stood at $44.4 million for Q4 2025, which was up 295.66% from $42.6 million recorded in Q3 2025.
- In the past 5 years, Angiodynamics' Receivables registered a high of $53.6 million during Q3 2022, and its lowest value of $33.2 million during Q1 2021.
- For the 5-year period, Angiodynamics' Receivables averaged around $44.9 million, with its median value being $43.5 million (2024).
- Its Receivables has fluctuated over the past 5 years, first surged by 5130.45% in 2022, then tumbled by 2048.44% in 2024.
- Quarter analysis of 5 years shows Angiodynamics' Receivables stood at $38.2 million in 2021, then surged by 38.34% to $52.9 million in 2022, then decreased by 2.36% to $51.6 million in 2023, then fell by 16.37% to $43.2 million in 2024, then increased by 2.96% to $44.4 million in 2025.
- Its Receivables was $44.4 million in Q4 2025, compared to $42.6 million in Q3 2025 and $42.9 million in Q2 2025.